Page 2 - பென்சில்வேனியா நிலை பல்கலைக்கழகம் கல்லூரி ஆஃப் மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பென்சில்வேனியா நிலை பல்கலைக்கழகம் கல்லூரி ஆஃப் மருந்து. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பென்சில்வேனியா நிலை பல்கலைக்கழகம் கல்லூரி ஆஃப் மருந்து Today - Breaking & Trending Today

Gemini Therapeutics Appoints Samuel Barone, M.D., as Chief Medical Officer


Press release content from Business Wire. The AP news staff was not involved in its creation.
Gemini Therapeutics Appoints Samuel Barone, M.D., as Chief Medical Officer
April 12, 2021 GMT
CAMBRIDGE, Mass. (BUSINESS WIRE) Apr 12, 2021
Gemini Therapeutics, Inc. (Nasdaq: GMTX), a clinical stage precision medicine company developing innovative treatments for genetically defined age-related macular degeneration (AMD) and linked ocular disorders, today announced the appointment of Samuel Barone, M.D., as Gemini’s Chief Medical Officer, effective immediately.
“We are thrilled to welcome Sam to Gemini as Chief Medical Officer, where he will bring his expertise as a board-certified ophthalmologist specializing in the treatment of retinal and macular diseases,” said Jason Meyenburg, Chief Executive Officer of Gemini Therapeutics. “As we continue to advance our clinical pipeline, we will benefit tremendously from his two-plus decades of clinical and development e ....

New York , United States , Boston College , San Diego , United Kingdom , Sherri Spear , Joshua Mansbach , Jason Meyenburg , Marce Uknis , Samuel Barone , University Of California , United States Air , Office Of Cellular , Drug Administration , Pennsylvania State University College Of Medicine , Andrews Air Force , Gemini Therapeutics Inc , Chief Medical Officer , Chief Executive Officer , Gemini Therapeutics , Senior Vice President , Adverum Biotechnologies , Avalanche Biotechnologies , Chief Medical , Medical Officer , Gene Therapies ,

Briefs on local businesspeople, including Paul Brassil, Robyn Nasuti, Sean Terrell, Kevin Haley and Dana Drissel


Paul Brassil of
Medfield has joined the company as senior vice president/chief information officer and will oversee PCU’s information technology and digital innovation efforts.
Brassil has more than 25 years of experience in the information technology leadership field with entities such as Commonwealth Medicine (a division of UMass Medical School), the Federal Reserve Bank of Boston, EMC Corp. and Siemens IT Solutions and Services Inc.
He holds an MS in computer information systems from Bentley University in
Waltham and a BA in Business Administration from Bridgewater State University.
Brassil s community involvement spans initiatives focused on workforce development and industry leadership serving as a member of the Tech Hire Advisory Group of Boston’s Private Industry Council (comprised of Boston CIOs developing summer intern programs for low/moderate income students in the Boston Public Schools); an adviser for Fintech Women (helping women in banking ....

Boston College , United States , Mcdaniel College , University Of Chicago , San Francisco , Eckerd College , New England College , New Hampshire , University Of Massachusetts Medical School , New Enterprise , United Kingdom , West Hollywood , North Easton , New York , New England Baptist Hospital , Tufts Medical Center , Milford Regional Medical Center , East Lansing , Stanford University , River Forest , Cape Cod , University Of Central Florida , City Of , Pays De La Loire , New Jersey , Great Hill ,

The American Cancer Society and Pfizer Launch Community Grants Focused on Reducing Prostate Cancer Disparities Among Black Men


The American Cancer Society and Pfizer Launch Community Grants Focused on Reducing Prostate Cancer Disparities Among Black Men
News provided by
Share this article
Share this article
ATLANTA, March 3, 2021 /PRNewswire/ The American Cancer Society and Pfizer Global Medical Grants are collaborating and have awarded a new competitive grant opportunity focused on addressing prostate cancer disparities impacting Black men.
The grants, funded by Pfizer Global Medical Grants and overseen by the American Cancer Society, are aimed at reducing gaps in care and barriers to treatment, and were awarded through a competitive selection process.
Cancer is a disease that affects everyone, but it doesn t affect everyone equally. Blacks experience more illness, worse outcomes, and premature death compared to whites in the United States. Further, Black people have the highest death rate and shortest survival of any racial/ethnic group in the United States for most cancers. B ....

United States , Emory University , Dana Farber Cancer Institute , Pennsylvania State University , Laura Makaroff , Dany Habr , Mary Center , Pennsylvania State University College Of Medicine , Central Florida Pharmacy Council , Henry Ford Health System , American Cancer Society , Pfizer Global Medical Grants , Early Detection , American Cancer , Chief Medical Officer , Florida Pharmacy Council , Farber Cancer Institute , Ford Health System , State University College , ஒன்றுபட்டது மாநிலங்களில் , உணர்ச்சி பல்கலைக்கழகம் , டானா ஃபார்‌பர் புற்றுநோய் நிறுவனம் , பென்சில்வேனியா நிலை பல்கலைக்கழகம் , லாரா மககரோப்ப் , மேரி மையம் , பென்சில்வேனியா நிலை பல்கலைக்கழகம் கல்லூரி ஆஃப் மருந்து ,

Dyne Therapeutics Appoints Ashish Dugar, Ph.D., MBA, Senior Vice President, Global Head of Medical Affairs


Dyne Therapeutics Appoints Ashish Dugar, Ph.D., MBA, Senior Vice President, Global Head of Medical Affairs
February 08, 2021 07:30 ET
| Source:
Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc.
Waltham, Massachusetts, UNITED STATES
Dr. Dugar Brings Over 20 Years of Experience in Medical Affairs, Clinical and Commercial Development, and Real-World Evidence, Including in Rare Muscle Disease
WALTHAM, Mass., Feb. 08, 2021 (GLOBE NEWSWIRE) Dyne Therapeutics, Inc. (Nasdaq: DYN), a muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced the appointment of Ashish Dugar, Ph.D., MBA, as senior vice president, global head of medical affairs. Dr. Dugar brings over 20 years of broad experience across medical affairs, clinical and commercial development, and real-world evidence (RWE) generation. ....

United States , Amy Reilly , Ashish Dugar , Joshua Brumm , Cellular Therapies Inc , National Institutes Of Health , Pennsylvania State University , University Of Michigan School Public Health , Pennsylvania State University College Of Medicine , Exchange Commission , Pfizer Inc , Sarepta Therapeutics Inc , Dyne Therapeutics Inc , Dugar Brings Over , Medical Affairs , Commercial Development , Real World Evidence , Rare Muscle , Sarepta Therapeutics , Intra Cellular Therapies , National Institutes , Michigan School , Pennsylvania State University College , Private Securities Litigation Reform Act , Dyne Therapeutics , Nasdaq Dyn ,